SEC Form 4 · accession 0001179110-15-009279

ABBOTT LABORATORIES · ABT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Senior Vice President

Period of report

Jun 3, 2015

Accepted (ET)

Jun 5, 2015 · 6:05 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000001800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common shares without par value	Jun 3, 2015	M	5,200	$25.2461	A	30,806	D
Common shares without par value	Jun 3, 2015	M	5,300	$26.6973	A	36,106	D
Common shares without par value	Jun 3, 2015	S	10,500	$49.00	D	25,606	D
Common shares without par value^F1	holding	—	—		—	2,711	I	Profit Sharing Trust
Common shares without par value^F2	holding	—	—		—	2,966	I	By daughter
Common shares without par value^F2	holding	—	—		—	2,967	I	By daughter
Common shares without par value^F3	holding	—	—		—	2,966	I	By son

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option (right to buy)^F4	$25.2461	Jun 3, 2015	M	5,200	D	Feb 16, 2010	Feb 15, 2017	Common shares	5,200	0	D
Option (right to buy)^F4	$26.6973	Jun 3, 2015	M	5,300	D	Feb 15, 2011	Feb 14, 2018	Common shares	5,300	0	D

F1Balance in the Abbott Laboratories Stock Retirement Trust as of June 4, 2015.
F2The reporting person disclaims beneficial ownership of all securities held by his daughter.
F3The reporting person disclaims beneficial ownership of all securities held by his son.
F4Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).